InfuSystem Holdings, Inc.
INFU
AMEX·Healthcare·Medical - Devices·Mkt cap $247.0M
$12.24
▲ +0.49%
P/E
58.20
Mkt Cap
$247.0M
52-Wk Range
$7.29–$12.97
52-Week Range
$7.29 - $12.97
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 19.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
2 risks
- Above-average volatility (beta 1.5).
- Premium valuation to sector peers
Growth
Strong growth ahead
Value
Premium valuation to sector peers
Momentum
Hot
+32.5% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying INFU right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 4, 2026
Reported EPS of $0.15 vs $0.11 consensus (+42.9% surprise). Revenue of $36.9M vs $36.4M expected (+1.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+42.9%
Revenue trend · last 2Q
—
+3%
Q1 26
Q2 26
$33.7M
$36.9M
Margins · last 2Q
Gross
58.0%
Operating
11.2%
Profit
8.8%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: B. Riley · Aug 5, 2026
vs Industry
How INFU stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.